Diabetes
- Aspirin for primary prevention of atherosclerotic cardiovascular events
A more limited role for aspirin as primary prevention in patients at intermediate risk, with diabetes, and the elderly.
- Type of diabetes mellitus: Does it matter to the clinician?
Understanding the many faces of diabetes can make a difference in how clinicians select glucose-lowering therapy.
- Diabetes management
Information was omitted from Table 1 on page 596 of the article, Makin V, Lansang MC. Diabetes management: Beyond hemoglobin A1c. Cleve Clin J Med 2019; 86(9):595–600. doi:10.3949/ccjm.86a.18031
- Clinical outcomes in diabetes: It’s not just the glucose (and it’s not so simple)
As we dig deeper into the reduction in cardiovascular deaths seen with some newer drugs, several questions arise.